Anne-Sofie Johansson
Research Subjects
Anne-Sofie Johansson has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Ece Somuncular
Center för Hematology and Regenerative Medicine, Stockholm, Sweden
4 shared publications- Sidinh Luc
Haematopoietic Stem Cell Laboratory, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK
4 shared publications - Hong Qian
Center for Hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
3 shared publications - Tsu-Yi Su
Department of Medicine Huddinge -MedH Karolinska Institutet 2024 Stockholm Stockholm Sweden
3 shared publications Aurora Forlani
Center för Hematology and Regenerative Medicine, Stockholm, Sweden
2 shared publicationsCharlotte Gustafsson
Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
2 shared publications
Latest Publications
- Open Access
- 2 January 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 103 (1) , e70083
LTB4 Activates the MAP Kinase Pathway in Endothelial Cells to Cause Long‐Lasting Neutrophil Tethering, MCP ‐1 and NO Releases
Leukotriene B 4 (LTB 4 ), a potent chemotactic and immune‐modulating eicosanoid, signals via two receptors (BLT 1 and BLT 2 ), leading to rapid but transient migratory, adhesive and secretory responses in phagocytes. Previously, we reported that BLT 1 is the predominating BLT in human umbilical vein endothelial cells (HUVEC). However, little is known about how ligation of these receptors affects adhesive and secretory endothelial responses over time. Here, we demonstrate that in HUVEC, LTB 4 dose‐dependently and stereospecifically causes a biphasic tethering of neutrophils, where the second phase is robust, similar to that induced by lipopolysaccharide, and persists for 3–8 h. LTB 4 also causes up‐regulation of E‐selectin, ICAM‐1 and VCAM‐1 and release of MCP‐1 and nitric oxide (but not of IL‐8 or HMGB1). These responses appeared to be mediated via BLT 1 and BLT 2 as judged by BLT 1 shRNA gene silencing and/or treatment with BLT 1 and BLT 2 specific antagonists prior to LTB 4 activation of HUVEC. Moreover, LTB 4 responses used primarily the MAP kinase/Erk pathway. Our findings suggest a new role for LTB 4 not only in early but also in late vascular inflammatory responses.
- 2 January 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 103 (1) , e70083
Open AccessLTB4 Activates the MAP Kinase Pathway in Endothelial Cells to Cause Long‐Lasting Neutrophil Tethering, MCP ‐1 and NO Releases
Leukotriene B 4 (LTB 4 ), a potent chemotactic and immune‐modulating eicosanoid, signals via two receptors (BLT 1 and BLT 2 ), leading to rapid but transient migratory, adhesive and secretory responses in phagocytes. Previously, we reported that BLT 1 is the predominating BLT in human umbilical vein endothelial cells (HUVEC). However, little is known about how ligation of these receptors affects adhesive and secretory endothelial responses over time. Here, we demonstrate that in HUVEC, LTB 4 dose‐dependently and stereospecifically causes a biphasic tethering of neutrophils, where the second phase is robust, similar to that induced by lipopolysaccharide, and persists for 3–8 h. LTB 4 also causes up‐regulation of E‐selectin, ICAM‐1 and VCAM‐1 and release of MCP‐1 and nitric oxide (but not of IL‐8 or HMGB1). These responses appeared to be mediated via BLT 1 and BLT 2 as judged by BLT 1 shRNA gene silencing and/or treatment with BLT 1 and BLT 2 specific antagonists prior to LTB 4 activation of HUVEC. Moreover, LTB 4 responses used primarily the MAP kinase/Erk pathway. Our findings suggest a new role for LTB 4 not only in early but also in late vascular inflammatory responses.
- Top Cited PapersOpen Access
- 11 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets
Age is a risk factor for hematologic malignancies. Attributes of the aging hematopoietic system include increased myelopoiesis, impaired adaptive immunity, and a functional decline of the hematopoietic stem cells (HSCs) that maintain hematopoiesis. Changes in the composition of diverse HSC subsets have been suggested to be responsible for age-related alterations, however, the underlying regulatory mechanisms are incompletely understood in the context of HSC heterogeneity. In this study, we investigated how distinct HSC subsets, separated by CD49b, functionally and molecularly change their behavior with age. We demonstrate that the lineage differentiation of both lymphoid-biased and myeloid-biased HSC subsets progressively shifts to a higher myeloid cellular output during aging. In parallel, we show that HSCs selectively undergo age-dependent gene expression and gene regulatory changes in a progressive manner, which is initiated already in the juvenile stage. Overall, our studies suggest that aging intrinsically alters both cellular and molecular properties of HSCs.
- 11 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Top Cited PapersOpen AccessAging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets
Age is a risk factor for hematologic malignancies. Attributes of the aging hematopoietic system include increased myelopoiesis, impaired adaptive immunity, and a functional decline of the hematopoietic stem cells (HSCs) that maintain hematopoiesis. Changes in the composition of diverse HSC subsets have been suggested to be responsible for age-related alterations, however, the underlying regulatory mechanisms are incompletely understood in the context of HSC heterogeneity. In this study, we investigated how distinct HSC subsets, separated by CD49b, functionally and molecularly change their behavior with age. We demonstrate that the lineage differentiation of both lymphoid-biased and myeloid-biased HSC subsets progressively shifts to a higher myeloid cellular output during aging. In parallel, we show that HSCs selectively undergo age-dependent gene expression and gene regulatory changes in a progressive manner, which is initiated already in the juvenile stage. Overall, our studies suggest that aging intrinsically alters both cellular and molecular properties of HSCs.
- Open Access
- 14 September 2023
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 12 (11) , 720-726
Combination of CD49b and CD229 Reveals a Subset of Multipotent Progenitors With Short-Term Activity Within the Hematopoietic Stem Cell Compartment
Hematopoiesis is maintained by hematopoietic stem cells (HSCs) that replenish all blood lineages throughout life. It is well-established that the HSC pool is functionally heterogeneous consisting of cells differing in longevity, self-renewal ability, cell proliferation, and lineage differentiation. Although HSCs can be identified through the Lineage–Sca-1+c-Kit+CD48–CD34–CD150+ immunophenotype, the cell surface marker combination does not permit absolute purification of functional HSCs with long-term reconstituting ability. Therefore, prospective isolation of long-term HSCs is crucial for mechanistic understanding of the biological functions of HSCs and for resolving functional heterogeneity within the HSC population. Here, we show that the combination of CD229 and CD49b cell surface markers within the phenotypic HSC compartment identifies a subset of multipotent progenitor (MPP) cells with high proliferative activity and short-term reconstituting ability. Thus, the addition of CD229 and CD49b to conventional HSC markers permits prospective isolation of functional HSCs by distinguishing MPPs in the HSC compartment.
- 14 September 2023
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 12 (11) , 720-726
Open AccessCombination of CD49b and CD229 Reveals a Subset of Multipotent Progenitors With Short-Term Activity Within the Hematopoietic Stem Cell Compartment
Hematopoiesis is maintained by hematopoietic stem cells (HSCs) that replenish all blood lineages throughout life. It is well-established that the HSC pool is functionally heterogeneous consisting of cells differing in longevity, self-renewal ability, cell proliferation, and lineage differentiation. Although HSCs can be identified through the Lineage–Sca-1+c-Kit+CD48–CD34–CD150+ immunophenotype, the cell surface marker combination does not permit absolute purification of functional HSCs with long-term reconstituting ability. Therefore, prospective isolation of long-term HSCs is crucial for mechanistic understanding of the biological functions of HSCs and for resolving functional heterogeneity within the HSC population. Here, we show that the combination of CD229 and CD49b cell surface markers within the phenotypic HSC compartment identifies a subset of multipotent progenitor (MPP) cells with high proliferative activity and short-term reconstituting ability. Thus, the addition of CD229 and CD49b to conventional HSC markers permits prospective isolation of functional HSCs by distinguishing MPPs in the HSC compartment.
- Open Access
Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets
Age is a risk factor for hematologic malignancies. Attributes of the aging hematopoietic system include increased myelopoiesis, impaired adaptive immunity, and a functional decline of the hematopoietic stem cells (HSCs) that maintain hematopoiesis. Changes in the composition of diverse HSC subsets have been suggested to be responsible for age-related alterations, however, the underlying regulatory mechanisms are incompletely understood in the context of HSC heterogeneity. In this study, we investigated how distinct HSC subsets, separated by CD49b, functionally and molecularly change their behavior with age. We demonstrate that blood lineage differentiation progressively shifts to a higher myeloid cellular output in both lymphoid-biased and myeloid-biased HSC subsets during aging. In parallel, we show that HSCs selectively undergo age-dependent gene expression and gene regulatory molecular changes in a progressive manner, which is initiated already in the pre-adult stage. Overall, our studies suggest that aging intrinsically alters both cellular and molecular properties of HSCs. Highlights: With age a gradual shift towards myeloid differentiation occurs in both myeloid-biased and lymphoid-biased enriched HSC subsets. Age-related molecular changes preferentially occur in HSCs. Functionally distinct HSC subsets with high transcriptional similarity can be distinguished on the epigenetic level. HSC aging is associated with a progressive increase in chromatin accessibility.
Open AccessAging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets
Age is a risk factor for hematologic malignancies. Attributes of the aging hematopoietic system include increased myelopoiesis, impaired adaptive immunity, and a functional decline of the hematopoietic stem cells (HSCs) that maintain hematopoiesis. Changes in the composition of diverse HSC subsets have been suggested to be responsible for age-related alterations, however, the underlying regulatory mechanisms are incompletely understood in the context of HSC heterogeneity. In this study, we investigated how distinct HSC subsets, separated by CD49b, functionally and molecularly change their behavior with age. We demonstrate that blood lineage differentiation progressively shifts to a higher myeloid cellular output in both lymphoid-biased and myeloid-biased HSC subsets during aging. In parallel, we show that HSCs selectively undergo age-dependent gene expression and gene regulatory molecular changes in a progressive manner, which is initiated already in the pre-adult stage. Overall, our studies suggest that aging intrinsically alters both cellular and molecular properties of HSCs. Highlights: With age a gradual shift towards myeloid differentiation occurs in both myeloid-biased and lymphoid-biased enriched HSC subsets. Age-related molecular changes preferentially occur in HSCs. Functionally distinct HSC subsets with high transcriptional similarity can be distinguished on the epigenetic level. HSC aging is associated with a progressive increase in chromatin accessibility.
- Open Access
- 26 July 2023
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220 (10)
Skin mesenchymal niches maintain and protect AML-initiating stem cells
Leukemia cutis or leukemic cell infiltration in skin is one of the common extramedullary manifestations of acute myeloid leukemia (AML) and signifies a poorer prognosis. However, its pathogenesis and maintenance remain understudied. Here, we report massive AML cell infiltration in the skin in a transplantation-induced MLL-AF9 AML mouse model. These AML cells could regenerate AML after transplantation. Prospective niche characterization revealed that skin harbored mesenchymal progenitor cells (MPCs) with a similar phenotype as BM mesenchymal stem cells. These skin MPCs protected AML-initiating stem cells (LSCs) from chemotherapy in vitro partially via mitochondrial transfer. Furthermore, Lama4 deletion in skin MPCs promoted AML LSC proliferation and chemoresistance. Importantly, more chemoresistant AML LSCs appeared to be retained in Lama4−/− mouse skin after cytarabine treatment. Our study reveals the characteristics and previously unrecognized roles of skin mesenchymal niches in maintaining and protecting AML LSCs during chemotherapy, meriting future exploration of their impact on AML relapse.
- 26 July 2023
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220 (10)
Open AccessSkin mesenchymal niches maintain and protect AML-initiating stem cells
Leukemia cutis or leukemic cell infiltration in skin is one of the common extramedullary manifestations of acute myeloid leukemia (AML) and signifies a poorer prognosis. However, its pathogenesis and maintenance remain understudied. Here, we report massive AML cell infiltration in the skin in a transplantation-induced MLL-AF9 AML mouse model. These AML cells could regenerate AML after transplantation. Prospective niche characterization revealed that skin harbored mesenchymal progenitor cells (MPCs) with a similar phenotype as BM mesenchymal stem cells. These skin MPCs protected AML-initiating stem cells (LSCs) from chemotherapy in vitro partially via mitochondrial transfer. Furthermore, Lama4 deletion in skin MPCs promoted AML LSC proliferation and chemoresistance. Importantly, more chemoresistant AML LSCs appeared to be retained in Lama4−/− mouse skin after cytarabine treatment. Our study reveals the characteristics and previously unrecognized roles of skin mesenchymal niches in maintaining and protecting AML LSCs during chemotherapy, meriting future exploration of their impact on AML relapse.
- Open Access
FOXO dictate initiation of B cell development and myeloid restriction in common lymphoid progenitors
The development of B cells relies on an intricate network of transcription factors critical for developmental progression and lineage commitment. In the B cell developmental trajectory, a temporal switch from predominant Foxo3 to Foxo1 expression occurs at the CLP stage. Utilizing VAV-iCre mediated conditional deletion, we found that the loss of FOXO3 impaired B cell development from LMPP down to B cell precursors, while the loss of FOXO1 impaired B cell commitment and resulted in a complete developmental block at the CD25 negative proB cell stage. Strikingly, the combined loss of FOXO1 and FOXO3 resulted in the failure to restrict the myeloid potential of CLPs and the complete loss of the B cell lineage. This is underpinned by the failure to enforce the early B-lineage gene regulatory circuitry upon a predominantly pre-established open chromatin landscape. Altogether, this demonstrates that FOXO3 and FOXO1 cooperatively govern early lineage restriction and initiation of B-lineage commitment in CLPs. SUMMARY: Common lymphoid progenitors co-express the transcription factors FOXO1 and FOXO3. Removing FOXO1 and FOXO3 at this developmental stage results in regained myeloid potential, failed establishment of the early B cell gene regulatory program, and the complete loss of the B cell lineage.
Open AccessFOXO dictate initiation of B cell development and myeloid restriction in common lymphoid progenitors
The development of B cells relies on an intricate network of transcription factors critical for developmental progression and lineage commitment. In the B cell developmental trajectory, a temporal switch from predominant Foxo3 to Foxo1 expression occurs at the CLP stage. Utilizing VAV-iCre mediated conditional deletion, we found that the loss of FOXO3 impaired B cell development from LMPP down to B cell precursors, while the loss of FOXO1 impaired B cell commitment and resulted in a complete developmental block at the CD25 negative proB cell stage. Strikingly, the combined loss of FOXO1 and FOXO3 resulted in the failure to restrict the myeloid potential of CLPs and the complete loss of the B cell lineage. This is underpinned by the failure to enforce the early B-lineage gene regulatory circuitry upon a predominantly pre-established open chromatin landscape. Altogether, this demonstrates that FOXO3 and FOXO1 cooperatively govern early lineage restriction and initiation of B-lineage commitment in CLPs. SUMMARY: Common lymphoid progenitors co-express the transcription factors FOXO1 and FOXO3. Removing FOXO1 and FOXO3 at this developmental stage results in regained myeloid potential, failed establishment of the early B cell gene regulatory program, and the complete loss of the B cell lineage.
- 1 March 1994
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 13 (3) , 175-179
Phagolysosomal pH in Alveolar Macrophages from Smokers and Nonsmokers
1 Alveolar macrophages efficiently phagocytize particles deposited in the alveolar part of the lung. Phagolysosomal pH in alveolar macrophages from rabbits, dogs, baboons and guinea pigs is around 5 pH units. A low pH is of importance for clearance of inorganic particles and probably also for defence against bacteria and fungi. 2 Phagolysosomal pH in alveolar macrophages from smokers and non-smokers was measured using fluorescein-conjugated amorphous silica particles as a probe. pH was the same in both groups and similar to earlier studies on alveolar macrophages from animals. 3 The morphological picture between alveolar macrophages from smokers and non-smokers differed clearly with a high number of dense inclusions of great variation in size and shape in macrophages from smokers. Ingested test particles were located in all types of inclusions. 4 We conclude that phagolysosomal pH in human alveolar macrophages is similar to that in several animal species and that it is rather insensitive to influence from the environment.
- 1 March 1994
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 13 (3) , 175-179
Phagolysosomal pH in Alveolar Macrophages from Smokers and Nonsmokers
1 Alveolar macrophages efficiently phagocytize particles deposited in the alveolar part of the lung. Phagolysosomal pH in alveolar macrophages from rabbits, dogs, baboons and guinea pigs is around 5 pH units. A low pH is of importance for clearance of inorganic particles and probably also for defence against bacteria and fungi. 2 Phagolysosomal pH in alveolar macrophages from smokers and non-smokers was measured using fluorescein-conjugated amorphous silica particles as a probe. pH was the same in both groups and similar to earlier studies on alveolar macrophages from animals. 3 The morphological picture between alveolar macrophages from smokers and non-smokers differed clearly with a high number of dense inclusions of great variation in size and shape in macrophages from smokers. Ingested test particles were located in all types of inclusions. 4 We conclude that phagolysosomal pH in human alveolar macrophages is similar to that in several animal species and that it is rather insensitive to influence from the environment.